nigericin has been researched along with Familial Mediterranean Fever in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allatif, O; Belot, A; Benezech, S; Bourdonnay, E; Cantarini, L; Cimaz, R; Desjonquères, M; Duquesne, A; Gerfaud-Valentin, M; Henry, T; Hentgen, V; Jamilloux, Y; Laurent, A; Lefeuvre, L; Magnotti, F; Martin, A; Penel-Page, M; Py, BF; Rémy-Piccolo, V; Sève, P; Walzer, T | 1 |
1 other study(ies) available for nigericin and Familial Mediterranean Fever
| Article | Year |
|---|---|
Familial Mediterranean fever mutations are hypermorphic mutations that specifically decrease the activation threshold of the Pyrin inflammasome.
Topics: Adenosine Triphosphate; Adolescent; Adult; Antigens, Bacterial; Bacterial Proteins; Bacterial Toxins; Calcium-Binding Proteins; CARD Signaling Adaptor Proteins; Case-Control Studies; Cell Death; Child; Child, Preschool; Familial Mediterranean Fever; Female; Healthy Volunteers; Humans; Inflammasomes; Interleukin-18; Interleukin-1beta; Ionophores; Male; Middle Aged; Monocytes; Mutation; Nigericin; NLR Family, Pyrin Domain-Containing 3 Protein; Pyrin; rho GTP-Binding Proteins; Salmonella typhimurium | 2018 |